Home Biotech Deserves A Piece Of Every Dividend Growth Portfolio
 

Keywords :   


Biotech Deserves A Piece Of Every Dividend Growth Portfolio

2016-01-26 07:14:29| Biotech - Topix.net

Taking into account their projected EPS growth rates and potential for dividend growth, both companies, but in particular Gilead Sciences, are attractively valued relative to the market. Amgen became a pioneer in the biotech world when it became the first large biotech stock to begin paying a regular dividend in 2011.

Tags: growth piece portfolio biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Reddit shares jump after OpenAI ChatGPT deal
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
More »